Skip to content

Validation of Remote Photoplethysmography (rPPG)-Derived Cardiovascular Parameters Against Standard Clinical Measurements and Risk Scores in a Community

Validation of Remote Photoplethysmography (rPPG)-Derived Cardiovascular Parameters Against Standard Clinical Measurements and Risk Scores in a Community-Based Population in Semanan, Jakarta

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07502703
Enrollment
300
Registered
2026-03-31
Start date
2026-04-23
Completion date
2026-12-30
Last updated
2026-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Angina (Stable), Coronary Artery Disease (CAD), Diabetes (DM), Dyslipidemia, Heart Disease, Hypertension

Keywords

remote photoplethysmography, rPPG, cardiovascular risk, ASCVD, Framingham score, digital health, screening tool

Brief summary

The goal of this observational study is to evaluate whether a contactless camera-based technology, called remote photoplethysmography (rPPG), can accurately measure cardiovascular parameters and estimate cardiovascular risk in adults aged 30 years and older living in a community setting in Semanan, Jakarta. This study aims to determine if rPPG can be used as a simple and accessible tool for early cardiovascular screening. The main questions it aims to answer are: 1. Do cardiovascular parameters measured using rPPG (such as blood pressure, heart rate, and cardiac workload) agree with standard clinical measurements? 2. Do cardiovascular risk estimates generated by rPPG (such as ASCVD risk and Framingham heart age) correspond to risk calculations obtained using conventional clinical and laboratory methods? Researchers will compare results obtained from rPPG-based facial video scans with results from standard medical assessments, including blood pressure measurements, heart rate evaluation, and laboratory tests for cholesterol levels, to determine the level of agreement and accuracy. Participants will: 1. Undergo a short facial video scan (approximately 30-60 seconds) using an rPPG-based system 2. Receive standard clinical assessments, including blood pressure and heart rate measurements 3. Provide basic health information (such as age, sex, smoking status, and treatment history) Undergo simple laboratory testing for cholesterol levels This study is expected to help determine whether rPPG can be used as a reliable, non-invasive, and scalable screening tool for cardiovascular risk in community and primary healthcare settings.

Detailed description

Introduction Remote photoplethysmography (rPPG) is an emerging contactless technology that enables extraction of physiological signals from facial video, allowing estimation of cardiovascular parameters such as heart rate and blood pressure. With the growing burden of atherosclerotic cardiovascular disease (ASCVD), early and accessible risk screening tools are essential, particularly in community settings with limited access to laboratory-based assessments. Although established risk models such as the ASCVD and Framingham scores are widely used, their application often requires clinical and laboratory data that may not be readily available. The integration of rPPG-based measurements with cardiovascular risk estimation offers a promising approach; however, its clinical validity and agreement with standard methods remain insufficiently explored . Objective This study aims to evaluate the agreement and concordance between rPPG-derived cardiovascular parameters and standard clinical measurements, as well as to assess the alignment of rPPG-estimated ASCVD risk and Framingham heart age with conventional risk calculations. Methods This study will use an analytical observational cross-sectional design conducted in Kelurahan Semanan, Jakarta. Adult participants (≥30 years) will be recruited through community-based sampling. Each participant will undergo clinical anamnesis, physical examination (blood pressure and heart rate), and laboratory testing (total cholesterol and HDL). In parallel, rPPG-based facial video scans will be performed under standardized conditions to obtain systolic and diastolic blood pressure, mean arterial pressure, pulse pressure, heart rate, cardiac workload, ASCVD risk, and Framingham heart age. Framingham risk will be calculated using sex-specific equations based on clinical and laboratory variables. Agreement between rPPG and standard measurements will be assessed using Bland-Altman analysis, while correlations will be evaluated using Pearson or Spearman tests. Concordance for categorical risk classification will be analyzed using Cohen's Kappa. Expected Results It is expected that rPPG-derived heart rate will demonstrate good agreement with standard measurements, while blood pressure parameters will show moderate agreement. Additionally, rPPG-based ASCVD risk and Framingham heart age are anticipated to exhibit acceptable concordance with conventional risk calculations. These findings may support the potential role of rPPG as a preliminary screening and risk stratification tool in community-based and telemedicine settings.

Interventions

None listed

Sponsors

Tarumanagara University
Lead SponsorOTHER

Study design

Observational model
ECOLOGIC_OR_COMMUNITY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
30 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Adults aged ≥30 years 2. Willing to participate and provide informed consent 3. Able to undergo face scan, clinical examination, and laboratory testing

Exclusion criteria

1. Facial abnormalities interfering with rPPG signal acquisition 2. Inability to remain still during measurement 3. Severe clinical instability 4. Incomplete key variables

Design outcomes

Primary

MeasureTime frameDescription
Agreement of rPPG-Derived Blood Pressure with Standard MeasurementsDay 1Assessment of agreement between systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial pressure (MAP), and pulse pressure obtained from rPPG-based facial video analysis and standard measurements using aneroid or digital sphygmomanometers. Agreement will be evaluated using Bland-Altman analysis (mean difference and limits of agreement).
Agreement of rPPG-Derived Heart Rate and Cardiac WorkloadDay 1Evaluation of agreement between heart rate and cardiac workload obtained from rPPG and those measured using standard methods (palpation and pulse oximetry). Agreement will be analyzed using Bland-Altman and correlation analysis (Pearson/Spearman).
Concordance of rPPG-Based ASCVD Risk with Standard Risk CalculationDay 1Assessment of agreement and concordance between ASCVD risk (%) and risk categories (low, intermediate, high) estimated using rPPG and those calculated using conventional clinical and laboratory data. Concordance will be evaluated using Cohen's Kappa and correlation analysis.
Concordance of rPPG-Derived Framingham Heart AgeDay 1Evaluation of agreement between Framingham heart age estimated using rPPG-derived parameters and heart age calculated using standard Framingham risk equations based on clinical and laboratory variables. Agreement will be assessed using correlation and Bland-Altman analysis.

Countries

Indonesia

Contacts

CONTACTAlexander Halim Santoso, MD
alexanders@fk.untar.ac.id+6281381606869
CONTACTErnawati Ernawati, Dr
ernawati@fk.untar.ac.id+6281389048199
PRINCIPAL_INVESTIGATORErnawati Ernawati

Universitas Tarumanagara

STUDY_DIRECTORYohanes Firmansyah

Universitas Tarumanagara

STUDY_DIRECTORAlexander Halim Santoso

Universitas Tarumanagara

STUDY_DIRECTORDavid Wongso

DexWellness

STUDY_DIRECTORRatheesh Nair

Watch Your Health

STUDY_CHAIRSri Tiarti

Universitas Tarumanagara

STUDY_CHAIRNoer Saelan Tadjudin

Universitas Tarumanagara

PRINCIPAL_INVESTIGATORClement Drew

Universitas Tarumanagara

STUDY_DIRECTORZita Atzmardina

Universitas Tarumanagara

STUDY_DIRECTORAndria Priyana

Universitas Tarumanagara

STUDY_CHAIRPutu Tommy Yudha Sumatera Suyasa

Universitas Tarumanagara

STUDY_DIRECTORKieren Nathan Wong

Monash University

STUDY_DIRECTORJaydee Kirani Wong

Melbourne University

STUDY_CHAIRMeiske Yunithree Suparman

Universitas Tarumanagara

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 21, 2026